Skip to main content Skip to section navigation Skip to footer
Back to AchieveLifeSciences.com
Achieve Life Sciences, Inc. Investor Relations
  • Investors
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Information

Press Releases

News & Events

News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Aug 11, 2021 5:30am EDT

Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing and Administration Regimen

Aug 03, 2021 5:30am EDT

Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021

Jul 22, 2021 9:35am EDT

Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use

Jun 29, 2021 5:30am EDT

Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline

Jun 03, 2021 5:30am EDT

Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction

Jun 02, 2021 5:30am EDT

Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conference

May 27, 2021 4:05pm EDT

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 25, 2021 8:30am EDT

Achieve Life Sciences Announces Pricing of $20 Million Underwritten Public Offering

May 24, 2021 4:05pm EDT

Achieve Life Sciences Announces Proposed Underwritten Public Offering

May 13, 2021 4:05pm EDT

Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate Update

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • …Page 15
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2022 Achieve Life Sciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap